Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Zika Virus Infection | 6 | 2018 | 7 | 2.810 |
Why?
|
Guillain-Barre Syndrome | 5 | 2018 | 7 | 2.210 |
Why?
|
Cerebral Hemorrhage | 7 | 2020 | 131 | 1.670 |
Why?
|
Nervous System Diseases | 4 | 2020 | 149 | 1.560 |
Why?
|
Subarachnoid Hemorrhage | 4 | 2022 | 68 | 1.530 |
Why?
|
Thrombolytic Therapy | 3 | 2016 | 55 | 1.100 |
Why?
|
Zika Virus | 5 | 2018 | 6 | 1.090 |
Why?
|
Myxoma | 2 | 2013 | 6 | 0.860 |
Why?
|
Heart Neoplasms | 2 | 2013 | 14 | 0.850 |
Why?
|
Encephalitis | 2 | 2023 | 18 | 0.830 |
Why?
|
Ultrasonography, Doppler, Transcranial | 3 | 2016 | 9 | 0.780 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 11 | 0.740 |
Why?
|
Brain Death | 1 | 2020 | 16 | 0.740 |
Why?
|
Occupational Health | 1 | 2020 | 21 | 0.740 |
Why?
|
Brain Edema | 1 | 2020 | 23 | 0.740 |
Why?
|
Apnea | 1 | 2020 | 17 | 0.740 |
Why?
|
Encephalocele | 1 | 2020 | 26 | 0.740 |
Why?
|
Brain Ischemia | 2 | 2022 | 72 | 0.710 |
Why?
|
Cerebrovascular Circulation | 2 | 2016 | 44 | 0.690 |
Why?
|
Hypothermia, Induced | 2 | 2013 | 22 | 0.650 |
Why?
|
Heart Arrest | 2 | 2013 | 58 | 0.630 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2018 | 30 | 0.620 |
Why?
|
Humans | 32 | 2023 | 29845 | 0.610 |
Why?
|
Critical Care | 4 | 2023 | 242 | 0.610 |
Why?
|
Environmental Pollution | 1 | 2017 | 2 | 0.580 |
Why?
|
Environmental Illness | 1 | 2017 | 2 | 0.580 |
Why?
|
Blood Cell Count | 1 | 2016 | 16 | 0.570 |
Why?
|
Tissue and Organ Procurement | 1 | 2015 | 34 | 0.490 |
Why?
|
Attitude to Health | 1 | 2015 | 98 | 0.470 |
Why?
|
Factor VIIa | 1 | 2013 | 9 | 0.450 |
Why?
|
Vitamin K | 1 | 2013 | 8 | 0.450 |
Why?
|
Blood Coagulation Factors | 1 | 2013 | 18 | 0.440 |
Why?
|
Anticoagulants | 2 | 2013 | 102 | 0.440 |
Why?
|
Warfarin | 1 | 2013 | 38 | 0.430 |
Why?
|
Pancreatitis | 1 | 2013 | 25 | 0.430 |
Why?
|
Brazil | 4 | 2023 | 37 | 0.430 |
Why?
|
Abducens Nerve Diseases | 1 | 2012 | 3 | 0.430 |
Why?
|
Aneurysm | 1 | 2012 | 11 | 0.430 |
Why?
|
Central Nervous System Diseases | 1 | 2012 | 21 | 0.420 |
Why?
|
Thrombosis | 1 | 2013 | 59 | 0.420 |
Why?
|
Leukocytosis | 3 | 2021 | 8 | 0.400 |
Why?
|
Neurology | 1 | 2013 | 105 | 0.390 |
Why?
|
Female | 15 | 2023 | 16426 | 0.380 |
Why?
|
Middle Aged | 10 | 2023 | 9960 | 0.360 |
Why?
|
Male | 13 | 2023 | 15868 | 0.350 |
Why?
|
Internship and Residency | 1 | 2013 | 213 | 0.340 |
Why?
|
Fever | 2 | 2016 | 40 | 0.330 |
Why?
|
Incidence | 4 | 2019 | 759 | 0.320 |
Why?
|
Age Factors | 4 | 2020 | 854 | 0.300 |
Why?
|
Disease Outbreaks | 2 | 2018 | 89 | 0.300 |
Why?
|
Hypoxia | 2 | 2020 | 63 | 0.290 |
Why?
|
Aging | 1 | 2016 | 1630 | 0.280 |
Why?
|
Epidemics | 1 | 2016 | 4 | 0.280 |
Why?
|
Fibrinolytic Agents | 1 | 2016 | 57 | 0.270 |
Why?
|
Adult | 8 | 2023 | 8746 | 0.270 |
Why?
|
Logistic Models | 3 | 2016 | 410 | 0.260 |
Why?
|
Telemedicine | 1 | 2016 | 99 | 0.240 |
Why?
|
Central Nervous System Infections | 1 | 2023 | 6 | 0.230 |
Why?
|
Brain Abscess | 1 | 2023 | 7 | 0.230 |
Why?
|
Meningitis | 1 | 2023 | 11 | 0.230 |
Why?
|
Databases, Factual | 3 | 2020 | 332 | 0.220 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2021 | 96 | 0.220 |
Why?
|
Cerebral Infarction | 2 | 2022 | 154 | 0.220 |
Why?
|
Stroke | 1 | 2016 | 294 | 0.220 |
Why?
|
Migraine Disorders | 1 | 2013 | 14 | 0.220 |
Why?
|
Vasospasm, Intracranial | 1 | 2022 | 17 | 0.210 |
Why?
|
Risk Factors | 7 | 2021 | 2466 | 0.210 |
Why?
|
Acute Disease | 3 | 2017 | 225 | 0.210 |
Why?
|
Weather | 2 | 2019 | 18 | 0.200 |
Why?
|
Treatment Outcome | 5 | 2021 | 3560 | 0.200 |
Why?
|
Odds Ratio | 2 | 2016 | 286 | 0.200 |
Why?
|
Aged | 7 | 2021 | 9619 | 0.190 |
Why?
|
Cerebrum | 1 | 2021 | 10 | 0.190 |
Why?
|
Cerebral Amyloid Angiopathy | 2 | 2019 | 118 | 0.190 |
Why?
|
Fatal Outcome | 1 | 2020 | 60 | 0.190 |
Why?
|
Hyperglycemia | 1 | 2020 | 34 | 0.180 |
Why?
|
Blood Glucose | 1 | 2020 | 112 | 0.180 |
Why?
|
Retrospective Studies | 6 | 2023 | 3324 | 0.170 |
Why?
|
Cerebral Angiography | 3 | 2022 | 30 | 0.170 |
Why?
|
Young Adult | 3 | 2017 | 1969 | 0.170 |
Why?
|
Campylobacter Infections | 1 | 2018 | 11 | 0.160 |
Why?
|
Prognosis | 4 | 2020 | 874 | 0.160 |
Why?
|
Cardiovascular Diseases | 1 | 2013 | 411 | 0.160 |
Why?
|
Neuritis | 1 | 2017 | 2 | 0.150 |
Why?
|
Electromyography | 1 | 2017 | 79 | 0.150 |
Why?
|
Neuroimaging | 1 | 2018 | 138 | 0.150 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2017 | 146 | 0.140 |
Why?
|
Hypothermia | 1 | 2017 | 7 | 0.140 |
Why?
|
Pregnancy | 1 | 2018 | 387 | 0.140 |
Why?
|
Ohio | 1 | 2016 | 9 | 0.140 |
Why?
|
Intracranial Aneurysm | 1 | 2016 | 29 | 0.140 |
Why?
|
Critical Illness | 1 | 2017 | 127 | 0.140 |
Why?
|
Models, Theoretical | 1 | 2016 | 94 | 0.130 |
Why?
|
Infant, Newborn | 1 | 2018 | 618 | 0.130 |
Why?
|
Anemia | 1 | 2016 | 99 | 0.130 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 558 | 0.120 |
Why?
|
Global Health | 1 | 2015 | 55 | 0.120 |
Why?
|
Patient Admission | 2 | 2021 | 30 | 0.120 |
Why?
|
Time Factors | 3 | 2020 | 1641 | 0.110 |
Why?
|
Plasma | 1 | 2013 | 34 | 0.110 |
Why?
|
Hypolipidemic Agents | 1 | 2013 | 22 | 0.110 |
Why?
|
Hypertriglyceridemia | 1 | 2013 | 20 | 0.110 |
Why?
|
Administration, Oral | 1 | 2013 | 144 | 0.110 |
Why?
|
Angiography | 1 | 2012 | 39 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 2 | 2020 | 1247 | 0.100 |
Why?
|
Predictive Value of Tests | 2 | 2020 | 532 | 0.100 |
Why?
|
Cohort Studies | 1 | 2017 | 1953 | 0.100 |
Why?
|
Echocardiography | 1 | 2012 | 172 | 0.100 |
Why?
|
Hospital Mortality | 2 | 2023 | 140 | 0.100 |
Why?
|
Risk Assessment | 2 | 2021 | 685 | 0.090 |
Why?
|
Biomarkers | 2 | 2020 | 704 | 0.090 |
Why?
|
HIV Infections | 1 | 2017 | 997 | 0.090 |
Why?
|
Atmospheric Pressure | 2 | 2019 | 12 | 0.080 |
Why?
|
Patient Discharge | 2 | 2021 | 151 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 778 | 0.080 |
Why?
|
United States | 1 | 2015 | 2346 | 0.080 |
Why?
|
Administration, Intravenous | 1 | 2016 | 28 | 0.070 |
Why?
|
Computed Tomography Angiography | 1 | 2016 | 24 | 0.070 |
Why?
|
Forecasting | 1 | 2016 | 117 | 0.070 |
Why?
|
Chicago | 2 | 2020 | 866 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 147 | 0.070 |
Why?
|
Neurologic Examination | 1 | 2016 | 154 | 0.070 |
Why?
|
Multivariate Analysis | 1 | 2016 | 332 | 0.060 |
Why?
|
Prospective Studies | 2 | 2020 | 1824 | 0.060 |
Why?
|
Aged, 80 and over | 2 | 2020 | 4930 | 0.060 |
Why?
|
Rewarming | 1 | 2013 | 1 | 0.060 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2013 | 4 | 0.060 |
Why?
|
Shivering | 1 | 2013 | 3 | 0.060 |
Why?
|
Epidemiologic Methods | 1 | 2013 | 20 | 0.060 |
Why?
|
Hypertension | 2 | 2018 | 272 | 0.060 |
Why?
|
Body Temperature | 1 | 2013 | 59 | 0.060 |
Why?
|
Survivors | 1 | 2013 | 57 | 0.060 |
Why?
|
Magnetic Resonance Angiography | 1 | 2021 | 30 | 0.050 |
Why?
|
Leukocyte Count | 1 | 2021 | 92 | 0.050 |
Why?
|
Intensive Care Units | 1 | 2023 | 312 | 0.050 |
Why?
|
Adolescent | 1 | 2016 | 2334 | 0.050 |
Why?
|
Respiration, Artificial | 1 | 2021 | 109 | 0.040 |
Why?
|
Illinois | 1 | 2020 | 241 | 0.040 |
Why?
|
Comorbidity | 1 | 2020 | 504 | 0.040 |
Why?
|
Temperature | 1 | 2018 | 74 | 0.040 |
Why?
|
Disability Evaluation | 1 | 2021 | 327 | 0.040 |
Why?
|
Geriatric Assessment | 1 | 2020 | 221 | 0.040 |
Why?
|
Recovery of Function | 1 | 2020 | 291 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 237 | 0.040 |
Why?
|
Hospitalization | 1 | 2020 | 318 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2020 | 1462 | 0.030 |
Why?
|